Skip to main content

Advertisement

Table 2 Distribution of projected 5-year risk (%, UKPDS risk engine) of coronary and other vascular outcomes for randomized patients with no history of cardiovascular disease (n = 7664)

From: Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

Outcome measures Projected 5-year risk (%, from the UKPDS risk engine)
<5% 5%–<10% 10%–<15% 15%–<20% ≥20%
All CHD 24.6 37.0 20.7 9.5 8.2
Fatal CHD 56.1 26.8 9.9 4.6 2.6
All stroke 79.3 17.0 2.8 0.7 0.2
Fatal stroke 99.9 0.1 0.0 0.0 0.0